ID: ALA5181350

Max Phase: Preclinical

Molecular Formula: C14H14ClN5OS

Molecular Weight: 335.82

Representations

Canonical SMILES:  C[C@@H](N)c1cc(Cl)ccc1Cn1c(=S)[nH]c(=O)c2[nH]cnc21

Standard InChI:  InChI=1S/C14H14ClN5OS/c1-7(16)10-4-9(15)3-2-8(10)5-20-12-11(17-6-18-12)13(21)19-14(20)22/h2-4,6-7H,5,16H2,1H3,(H,17,18)(H,19,21,22)/t7-/m1/s1

Standard InChI Key:  SMTRVBMWPOQGJP-SSDOTTSWSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 335.82

Molecular Weight (Monoisotopic): 335.0608

AlogP: 2.50

#Rotatable Bonds: 3

Polar Surface Area: 92.49

Molecular Species: BASE

HBA: 5

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.16

CX Basic pKa: 9.35

CX LogP: 0.62

CX LogD: -0.18

Aromatic Rings: 3

Heavy Atoms: 22

QED Weighted: 0.64

Np Likeness Score: -1.27

References

1. Inghardt T, Antonsson T, Ericsson C, Hovdal D, Johannesson P, Johansson C, Jurva U, Kajanus J, Kull B, Michaëlsson E, Pettersen A, Sjögren T, Sörensen H, Westerlund K, Lindstedt EL..  (2022)  Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.,  65  (17.0): [PMID:36005476] [10.1021/acs.jmedchem.1c02141]

Source

Source(1):

• Scientific Literature